Recode Therapeutics

Developer of precision medicines for pulmonary diseases

placeDallas, Texas, United States calendar_todayFounded 2016 language recoderx.com

Social engagement

Social engagement: 17.5K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Orbimed, Colt Ventures.

Investor typeCountShare
Venture capital375%
Private equity125%

Recent activity

20 May 2026
Milestone
regulatory
16 May 2026
Event
American Thoracic Society International Conference (ATS2026)
27 Apr 2026
Leadership hire
Chief Medical Officer
Coming soon